Accelerated Dose Schedule of Cytarabine Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) in Complete Remission
Clinical trial NCT04914676 · TERMINATED
Trial details
- NCT number
- NCT04914676
- Sponsor
- University of Florida
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-08
- Primary completion
- 2024-01-12
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.